ZURCHER KANTONALBANK FINANCE (GUERNSEY) LIMITED | Market Closed - Swiss Exchange 11:20:00 2024-06-17 EDT | ||
| 96.14 USD | -1.61% |
|
| Current month | -0.28% | ||
| 1 month | -1.90% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-17 | 96.14 | -1.61% |
| 24-06-12 | 97.71 | +0.38% |
| 24-06-11 | 97.34 | +0.22% |
| 24-06-10 | 97.13 | +0.15% |
Delayed Quote Swiss Exchange
Last update June 17, 2024 at 11:20 am
More quotesStatic data
| Product type | sonstige Zertifikate |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | ZKB |
| Z08W6Z | |
| ISIN | CH1303978618 |
| Date issued | 2023-12-13 |
| Maturity | 2025-03-13 (269 Days) |
| Parity | 0.04 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | Beides |
| Currency | USD |
Technical Indicators
| Highest since issue | 100.1 $ |
|---|---|
| Lowest since issue | 96.14 $ |
| Spread | 7 $ |
| Spread % | 0.73% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.2
USD
Average target price
53.19
USD
Spread / Average Target
+29.11%
- Stock Market
- Certificates
- Z08W6Z Certificat
